HCRT and Hypoglycemia: However, hypoglycemia did not appear to stimulate orexinergic neuron activity (as measured by peripheral orexin A levels), nor did low dose SB-649868 have a significant effect on any endpoint, and therefore the ITT model could not be validated with regard to investigating pharmacotherapeutic effects on orexinergic pathways.